Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Non-steroidal Anti-inflammatory Drugs, Pleurodesis, Pneumothorax, Pain Management
In brief
Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended in a multimodal pain management to reduce pain intensity and to spare opioid use. However, there is a controversy in its use in pleurodesis surgery as it could block the process of pleurodesis in surgical pneumothorax. In addition, NSAIDs could increase the risk of pneumothorax recurrence. The investigators hypothesized that NSAIDs are safe during pleurodesis with a better pain management without increasing the risk of pneumothorax reccurence.
Key facts
- Study ID
- NCT06731647
- Run by
- Centre Hospitalier Universitaire, Amiens
- People needed
- 358
- Starts
- 2025-02-01
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2025-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age≥18-year-old
- pneumothorax with an indication of pleurodesis
- with or without minimal lung resection
- via thoracotomy or thoracoscopy
You may not qualify if…
- Minor patient
- Pregnant, parturient or breast-feeding patient
- Severe polytrauma (associated with the presence of a Vittel criterion)
- Purulent pleurisy
- Hemopneumothorax
- Lactose hyper sensibility
- Contraindications to NSAID
- Contraindications to tramadol
- Contraindications to paracetamol
- Curative anticoagulation
- Patients under guardians or deprived of their liberty
- Patient refusal
Where it is running
- Centre Hospitalier Universitaire d'Amiens — Amiens, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.